Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
BMJ Open. 2020 Oct 27;10(10):e033979. doi: 10.1136/bmjopen-2019-033979.
To estimate the cost of human papillomavirus (HPV)-based screening through community health campaigns (CHCs) and home-based testing.
CHCs and home-based testing in six communities in rural Western Kenya.
CHCs and home-based screening reached 2297 and 1002 women aged 25-65 years, respectively.
Outcome measures were overall cost per woman screened achieved through the CHCs and home-based testing and the cost per woman for each activity comprising the screening intervention.
The mean cost per woman screened through CHCs and home-based testing were similar, at $37.7 (range $26.4-$52.0) and $37.1 (range $27.6-$54.0), respectively. For CHCs, personnel represented 49% of overall cost, supplies 25%, services 5% and capital goods 23%. For home-based testing, these were: personnel 73%, supplies 25%, services 1% and capital goods 2%. A greater number of participants was associated with a lower cost per participant.
The mean cost per woman screened is comparable for CHC and home-based testing, with differences in type of input. The CHCs generally reached more eligible women in the six communities, whereas home-based strategies more efficiently reached populations with low screening rates.
NCT02124252.
通过社区卫生运动（CHC）和家庭检测估算人乳头瘤病毒（HPV）筛查的成本。
肯尼亚西部六个农村社区的 CHC 和家庭检测。
CHC 和家庭筛查分别覆盖了 2297 名和 1002 名年龄在 25-65 岁的女性。
通过 CHC 和家庭检测实现的每位女性筛查的总成本，以及筛查干预措施中每项活动的每位女性成本。
通过 CHC 和家庭检测的每位女性筛查的平均成本相似，分别为 37.7 美元（范围 26.4-52.0）和 37.1 美元（范围 27.6-54.0）。对于 CHC，人员占总成本的 49%，供应品占 25%，服务占 5%，资本货物占 23%。对于家庭检测，这些分别是：人员占 73%，供应品占 25%，服务占 1%，资本货物占 2%。参与者人数越多，每位参与者的成本就越低。
CHC 和家庭检测的每位女性筛查平均成本相当，投入类型存在差异。CHC 通常在六个社区中覆盖了更多符合条件的女性，而家庭策略则更有效地覆盖了筛查率较低的人群。
NCT02124252。
